Mr. Moody joined PaxVax in 2016 as Executive Vice President and Chief Financial Officer. Prior to joining PaxVax, Mr. Moody served as Chief Financial Officer for the North American sector at BTG PLC. In this role, he served as an advisor to the Head of North America at BTG, a company valued at $5 billion, and was responsible for management and oversight of all financial functions for the British-based medical device/specialty pharmaceutical business. Prior to this role, Mr. Moody was Founder, Board Member and Chief Executive Officer for DOLORANA, Inc., where he oversaw all business functions for the preclinical company developing products for the management of inflammatory and neuropathic pain. Mr. Moody has also held senior finance roles in a number of public and private companies, including Chiron, where he was involved in their vaccines business and served as Vice President, Finance and Operations.